- Home
- / Stuart Therapeutics
Stuart Therapeutics
Total Funding
$11 M
Stuart Therapeutics Summary
Company Summary
- Overview
- Stuart Therapeutics is a biotechnology company that develops a tissue reparative platform for eye diseases. It offers PolyCol, a polypeptide sequence that is designed to repair damaged extracellular matrix (ECM) helical collagen.
- Type
- Private
- Status
- Active
- Founded
- 2018
- HQ
- Stuart, FL, US | view all locations
- Cybersecurity rating
Table of Contents
Key People
Robert O. Baratta, Chairman, Chief Medical Officer and Head of Product Development, Director
Diane Black, Chairman of Audit Committee
Shawn DeLorey, EVP, Program Management
Operating MetricsView all
Expertise Areas
3
May, 2023